Literature DB >> 1892592

Toxicity and activity of purified trichosanthin.

P Ferrari1, M A Trabaud, M Rommain, E Mandine, R Zalisz, C Desgranges, P Smets.   

Abstract

Trichosanthin was purified from fresh Chinese root tubers of Trichosanthes kirilowii and evaluated for anti-HIV activity. Trichosanthin inhibited syncytium formation between infected H9 cells and uninfected Sup-T1 cells from 0.5 to 4 micrograms/ml. Trichosanthin also inhibited HIV replication in H9 and CEM-SS cells at 1 microgram/ml, but was toxic for MT-4 cells (HTLV-I-positive), at doses greater than 0.25 microgram/ml. This new purification procedure confirms the anti-HIV activity of trichosanthin on some cell lines in different biological assays.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1892592     DOI: 10.1097/00002030-199107000-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

1.  The membrane insertion of trichosanthin is membrane-surface-pH dependent.

Authors:  X F Xia; S F Sui
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

Review 2.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

3.  Trichosanthin, an initiator of the alternative complement activation pathway.

Authors:  X Chen; B L Ma
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

4.  Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex.

Authors:  J O Kahn; K J Gorelick; G Gatti; C J Arri; J D Lifson; J G Gambertoglio; A Bostrom; R Williams
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 5.  A Sixty-Year Research and Development of Trichosanthin, a Ribosome-Inactivating Protein.

Authors:  Jia-Qi Lu; Kam-Bo Wong; Pang-Chui Shaw
Journal:  Toxins (Basel)       Date:  2022-02-27       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.